Tor Olofsson (T Olofsson)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 24

Top Venues

Annals of the rheumatic diseases

ACR open rheumatology

RMD open

Arthritis & rheumatology (Hoboken, N.J.)

Skånes universitetssjukhus Lund

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Skånes universitetssjukhus Lund Sep 01 2008

Sweden

Specialist in Rheumatology, PhD :: Department of Rheumatology

Publications

Kristofer Andréasson, Tor Olofsson, Venu Lagishetty, Zaid Alrawi, Eline Klaassens, Savanne Holster, Roger Hesselstrand, Jonathan Patrick Jacobs, Johan Karlsson Wallman, Elizabeth R Volkmann
Treatment for Rheumatoid Arthritis Associated With Alterations in the Gastrointestinal Microbiota. ACR open rheumatology (2024)
Kristofer Andréasson, Tor Olofsson, Venu Lagishetty, Zaid Alrawi, Eline Klaassens, Savanne Holster, Roger Hesselstrand, Jonathan Patrick Jacobs, Johan Karlsson Wallman, Elizabeth R Volkmann
Treatment for Rheumatoid Arthritis Associated With Alterations in the Gastrointestinal Microbiota. ACR open rheumatology 6 (7) (2024)
Kristofer Andréasson, Tor Olofsson, Venu Lagishetty, Zaid Alrawi, Eline Klaassens, Savanne Holster, Roger Hesselstrand, Jonathan Patrick Jacobs, Johan Karlsson Wallman, Elizabeth R Volkmann
Treatment for Rheumatoid Arthritis Associated With Alterations in the Gastrointestinal Microbiota. ACR open rheumatology (2024)
Kristofer Andréasson, Tor Olofsson, Venu Lagishetty, Zaid Alrawi, Eline Klaassens, Savanne Holster, Roger Hesselstrand, Jonathan Patrick Jacobs, Johan Karlsson Wallman, Elizabeth R Volkmann
Treatment for Rheumatoid Arthritis Associated With Alterations in the Gastrointestinal Microbiota. ACR open rheumatology 6 (7) (2024)
Kristofer Andréasson, Tor Olofsson, Venu Lagishetty, Zaid Alrawi, Eline Klaassens, Savanne Holster, Roger Hesselstrand, Jonathan Patrick Jacobs, Johan Karlsson Wallman, Elizabeth R Volkmann
Treatment for Rheumatoid Arthritis Associated With Alterations in the Gastrointestinal Microbiota. ACR open rheumatology 6 (7) (2024)
Anna Eberhard, Daniela Di Giuseppe, Johan Askling, Stefan Bergman, Hannah Bower, Katerina Chatzidionysiou, Helena Forsblad-d'Elia, Alf Kastbom, Tor Olofsson, Thomas Frisell, Carl Turesson
Effectiveness of janus kinase inhibitors compared with biologic disease modifying anti-rheumatic drugs on pain reduction in rheumatoid arthritis: Results from a nationwide Swedish cohort study. Arthritis & rheumatology (Hoboken, N.J.) (2024)
Pasoon Hellamand, Marleen G H van de Sande, Michael T Nurmohamed, Ronald F Van Vollenhoven, Rosemary J Hollick, Ovidiu Rotariu, Žiga Rotar, Katja Perdan Pirkmajer, Dan Nordström, Anna-Mari Hokkanen, Brigitte Michelsen, Tore K Kvien, Bente Glintborg, Merete Lund Hetland, Mikkel Østergaard, Anne Gitte Loft, Karel Pavelka, Jakub Závada, Isabel Castrejon, Lucia Otero Varela, Bjorn Gudbjornsson, Olafur Palsson, Tor Olofsson, Johan Karlsson Wallman, Adrian Ciurea, Michael John Nissen, Tuba D Yildirim, Fatoş Önen, Catalin Codreanu, Corina Mogosan, Maria Jose Santos, Elsa Viera Sousa, Florenzo Iannone, Bruno Frediani, Lykke Midtbøll Ørnbjerg, Jos W R Twisk, Irene E van der Horst-Bruinsma
Sex differences in patient-reported outcomes and the association with clinical factors in axial spondyloarthritis patients treated with tumour necrosis factor inhibitors. Rheumatology (Oxford, England) (2024)
Ulf Lindström, Daniela di Giuseppe, Sofia Exarchou, Gerd-Marie Alenius, Tor Olofsson, Eva Klingberg, Lennart Jacobsson, Johan Askling, Johan K Wallman
Methotrexate treatment in early psoriatic arthritis in comparison to rheumatoid arthritis: an observational nationwide study. RMD open 9 (2) (2023)
Pedro M Machado, Martin Schaefer, Satveer K Mahil, Jean Liew, Laure Gossec, Nick Dand, Alexander Pfeil, Anja Strangfeld, Anne Constanze Regierer, Bruno Fautrel, Carla Gimena Alonso, Carla G S Saad, Christopher E M Griffiths, Claudia Lomater, Corinne Miceli-Richard, Daniel Wendling, Deshiré Alpizar-Rodriguez, Dieter Wiek, Elsa F Mateus, Emily Sirotich, Enrique Roberto Soriano, Francinne Machado Ribeiro, Felipe Omura, Frederico Rajão Martins, Helena Santos, Jonathan Dau, Jonathan N Barker, Jonathan S Hausmann, Kimmie L Hyrich, Lianne Gensler, Ligia Silva, Lindsay Jacobsohn, Loreto Carmona, Edgard Torres Dos Reis-Neto, Marcos David Zelaya, María de Los Ángeles Severina, Mark Yates, Maureen Dubreuil, Monique Gore-Massy, Nicoletta Romeo, Nigil Haroon, Paul Sufka, Rebecca Grainger, Rebecca Hasseli, Saskia Lawson-Tovey, Suleman Bhana, Thao Pham, Tor Olofsson, Wilson Bautista-Molano, Zachary S Wallace, Zenas Z N Yiu, Jinoos Yazdany, Philip C Robinson, Catherine H Smith
Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registries. Annals of the rheumatic diseases (2023)
Ulf Lindström, Daniela di Giuseppe, Sofia Exarchou, Gerd-Marie Alenius, Tor Olofsson, Eva Klingberg, Lennart Jacobsson, Johan Askling, Johan K Wallman
Methotrexate treatment in early psoriatic arthritis in comparison to rheumatoid arthritis: an observational nationwide study. RMD open 9 (2) (2023)
Ulf Lindström, Daniela di Giuseppe, Sofia Exarchou, Gerd-Marie Alenius, Tor Olofsson, Eva Klingberg, Lennart Jacobsson, Johan Askling, Johan K Wallman
Methotrexate treatment in early psoriatic arthritis in comparison to rheumatoid arthritis: an observational nationwide study. RMD open 9 (2) (2023)
Pedro M Machado, Martin Schaefer, Satveer K Mahil, Jean Liew, Laure Gossec, Nick Dand, Alexander Pfeil, Anja Strangfeld, Anne Constanze Regierer, Bruno Fautrel, Carla Gimena Alonso, Carla G S Saad, Christopher E M Griffiths, Claudia Lomater, Corinne Miceli-Richard, Daniel Wendling, Deshiré Alpizar-Rodriguez, Dieter Wiek, Elsa F Mateus, Emily Sirotich, Enrique Roberto Soriano, Francinne Machado Ribeiro, Felipe Omura, Frederico Rajão Martins, Helena Santos, Jonathan Dau, Jonathan N Barker, Jonathan S Hausmann, Kimmie L Hyrich, Lianne Gensler, Ligia Silva, Lindsay Jacobsohn, Loreto Carmona, Edgard Torres Dos Reis-Neto, Marcos David Zelaya, María de Los Ángeles Severina, Mark Yates, Maureen Dubreuil, Monique Gore-Massy, Nicoletta Romeo, Nigil Haroon, Paul Sufka, Rebecca Grainger, Rebecca Hasseli, Saskia Lawson-Tovey, Suleman Bhana, Thao Pham, Tor Olofsson, Wilson Bautista-Molano, Zachary S Wallace, Zenas Z N Yiu, Jinoos Yazdany, Philip C Robinson, Catherine H Smith
Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registries. Annals of the rheumatic diseases (2023)
C Roseman, Johan Karlsson Wallman, Anna Jöud, Maria E C Schelin, Jon Thorkell Einarsson, Elisabet Lindqvist, Jon Lampa, Meliha Crnkic Kapetanovic, Tor Olofsson
Persistent pain and its predictors after starting anti-tumour necrosis factor therapy in psoriatic arthritis: what is the role of inflammation control? Scandinavian journal of rheumatology (2023)
Pedro M Machado, Martin Schaefer, Satveer K Mahil, Jean Liew, Laure Gossec, Nick Dand, Alexander Pfeil, Anja Strangfeld, Anne Constanze Regierer, Bruno Fautrel, Carla Gimena Alonso, Carla G S Saad, Christopher E M Griffiths, Claudia Lomater, Corinne Miceli-Richard, Daniel Wendling, Deshiré Alpizar-Rodriguez, Dieter Wiek, Elsa F Mateus, Emily Sirotich, Enrique Roberto Soriano, Francinne Machado Ribeiro, Felipe Omura, Frederico Rajão Martins, Helena Santos, Jonathan Dau, Jonathan N Barker, Jonathan S Hausmann, Kimmie L Hyrich, Lianne Gensler, Ligia Silva, Lindsay Jacobsohn, Loreto Carmona, Edgard Torres Dos Reis-Neto, Marcos David Zelaya, María de Los Ángeles Severina, Mark Yates, Maureen Dubreuil, Monique Gore-Massy, Nicoletta Romeo, Nigil Haroon, Paul Sufka, Rebecca Grainger, Rebecca Hasseli, Saskia Lawson-Tovey, Suleman Bhana, Thao Pham, Tor Olofsson, Wilson Bautista-Molano, Zachary S Wallace, Zenas Z N Yiu, Jinoos Yazdany, Philip C Robinson, Catherine H Smith
Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registries. Annals of the rheumatic diseases (2023)
Valgerdur Sigurdardottir, Anna Engstrom, Patric Berling, Tor Olofsson, Linnea Oldsberg, Susannah Sadler, Devian Parra-Padilla, Lode Melis, Damon Willems
Cost-effectiveness analysis of bimekizumab for the treatment of active psoriatic arthritis in Sweden. Journal of medical economics (2023)
Pedro M Machado, Martin Schaefer, Satveer K Mahil, Jean Liew, Laure Gossec, Nick Dand, Alexander Pfeil, Anja Strangfeld, Anne Constanze Regierer, Bruno Fautrel, Carla Gimena Alonso, Carla G S Saad, Christopher E M Griffiths, Claudia Lomater, Corinne Miceli-Richard, Daniel Wendling, Deshiré Alpizar-Rodriguez, Dieter Wiek, Elsa F Mateus, Emily Sirotich, Enrique Roberto Soriano, Francinne Machado Ribeiro, Felipe Omura, Frederico Rajão Martins, Helena Santos, Jonathan Dau, Jonathan N Barker, Jonathan S Hausmann, Kimmie L Hyrich, Lianne Gensler, Ligia Silva, Lindsay Jacobsohn, Loreto Carmona, Edgard Torres Dos Reis-Neto, Marcos David Zelaya, María de Los Ángeles Severina, Mark Yates, Maureen Dubreuil, Monique Gore-Massy, Nicoletta Romeo, Nigil Haroon, Paul Sufka, Rebecca Grainger, Rebecca Hasseli, Saskia Lawson-Tovey, Suleman Bhana, Thao Pham, Tor Olofsson, Wilson Bautista-Molano, Zachary S Wallace, Zenas Z N Yiu, Jinoos Yazdany, Philip C Robinson, Catherine H Smith
Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registries. Annals of the rheumatic diseases (2023)
Elisabet Lindqvist, Tor Olofsson, Anna Jöud, Mats Geijer, Johan Karlsson Wallman, Elisabeth Mogard
How good is the agreement between clinical diagnoses and classification criteria fulfilment in axial spondyloarthritis? Results from the SPARTAKUS cohort. Scandinavian journal of rheumatology (2022)
Viggo Hamberg, Johan Karlsson Wallman, Elisabeth Mogard, Elisabet Lindqvist, Tor Olofsson, Kristofer Andréasson
Elevated fecal levels of the inflammatory biomarker calprotectin in early systemic sclerosis. Rheumatology international (2022)
Ulf Lindström, Karin Bengtsson, Tor Olofsson, Daniela Di Giuseppe, Bente Glintborg, Helena Forsblad-d'Elia, Lennart T H Jacobsson, Johan Askling
Anterior uveitis in patients with spondyloarthritis treated with secukinumab or tumour necrosis factor inhibitors in routine care: does the choice of biological therapy matter? Annals of the rheumatic diseases 80 (11) (2021)
Tor Olofsson, Johan Karlsson Wallman, Anna Jöud, Maria E C Schelin, Sofia Ernestam, Ronald van Vollenhoven, Saedis Saevarsdottir, Jon Lampa
Pain Over Two Years After Start of Biologic Versus Conventional Combination Treatment in Early Rheumatoid Arthritis: Results From a Swedish Randomized Controlled Trial. Arthritis care & research 73 (9) (2021)
Hanna Källmark, Jon T Einarsson, Jan-Åke Nilsson, Tor Olofsson, Tore Saxne, Pierre Geborek, Meliha Crnkic Kapetanovic
Sustained Remission in Patients With Rheumatoid Arthritis Receiving Triple Therapy Compared to Biologic Therapy: A Swedish Nationwide Register Study. Arthritis & rheumatology (Hoboken, N.J.) 73 (7) (2021)
Elisabeth Mogard, Tor Olofsson, Stefan Bergman, Ann Bremander, Lars Erik Kristensen, Jack Kvistgaard Olsen, Johan Karlsson Wallman, Elisabet Lindqvist
Chronic Pain and Assessment of Pain Sensitivity in Patients With Axial Spondyloarthritis: Results From the SPARTAKUS Cohort. The Journal of rheumatology 48 (11) (2020)
Johan Karlsson Wallman, Elisabeth Mogard, Jan Marsal, Kristofer Andréasson, Anna Jöud, Mats Geijer, Lars Erik Kristensen, Elisabet Lindqvist, Tor Olofsson
Response to: 'response to: irritable bowel syndrome symptoms in axial spondyloarthritis more common than among healthy controls: is it an overlooked comorbidity?' by Proft et al. Annals of the rheumatic diseases (2019)
Johan Karlsson Wallman, Elisabeth Mogard, Jan Marsal, Kristofer Andréasson, Anna Jöud, Mats Geijer, Lars Erik Kristensen, Elisabet Lindqvist, Tor Olofsson
Irritable bowel syndrome symptoms in axial spondyloarthritis more common than among healthy controls: is it an overlooked comorbidity? Annals of the rheumatic diseases 79 (1) (2019)

Tor Olofsson.css-eqlu8i{font-size:small;padding-left:4px;} (T Olofsson)

Publication Activity (10 Years)

Top Topics

Top Venues

Tor Olofsson (T Olofsson)